Ryan Sue, PharmD, RPh

Experience

• 

  AMCP

  Oct 2021 - Apr 2023

  Managed local AMCP chapter accounts and played a key role in recruitment and membership. Utilized Excel and organizational skills to track chapter funds and allocate finances for various events hosted throughout the year. Organized and coordinated lunch talks with professionals in the managed care and industry space. Provided UCSF pharmacy students with a broader range of exposure to roles in industry and managed care, as well as informative talks on managed care residencies vs fellowship for post-graduate training opportunities. Served as a liaison between AMCP and P1 class. Organized and advertised events, reached out to professionals for speakers and networking. Helped facilitate large AMCP chapter events and wrote the therapeutic window updating the School of Pharmacy on AMCP's year of events and granting of the Chapter Growth of the Year Award.

  • Pharmacy and Therapeutics Competition Coordinator

    Mar 2022 - Apr 2023

  • Director of Finance

    Feb 2022 - Apr 2023

  • Director of Professional Development

    Feb 2022 - Apr 2023

  • P1 Committee

    Oct 2021 - Feb 2022
• 

  CCHP

  Mar 2022 - Apr 2023

  Managed Care Intern

  •Researched and presented inclusion/exclusion of new drugs on the commercial formulary with CCHP and MedImpact P&T committees, covering multiple therapeutic areas including gastrointestinal, inflammation, and neuropsychiatric drugs.•Completed drug research, conducted literature searches and clinical trial critical appraisals, and presented formulary recommendations, utilizing current treatment guidelines and pivotal phase 3 research to construct sound recommendations and assess place in therapy as well as feasibility of reimbursement for CCHP members. •Authored prior authorization criteria to be included in the CCHP guidelines for the appropriate coverage of non-formulary drugs and updated the CCHP vaccine schedule biannually with the most current average wholesale unit prices. •Wrote monthly member newsletters to encourage up-to-date vaccinations and advocate for the health of plan members.Drugs reviewed and presented for P&T:- Qulipta (atogepant) for migraine prophylaxis- Voquezna Dual/Triple Pak (vonoprazan/amoxicillin/clarithromycin) for H. pylori- Talicia (omeprazole/amoxicillin/rifabutin) for H. pylori- Auvelity (dextromethorphan/bupropion) for Major Depressive Disorder- Skyrizi (risankizumab) for Crohn’s Disease Show less

• 

  UCSF Institute for Global Health Sciences

  Mar 2022 - Aug 2022

  FindCOVID Clinical Research Assistant

  • Coordinated and conducted interviews with individuals who had recently tested positive for COVID-19,assessed symptom improvement, and followed patients long-term to further evaluate lasting effects of COVID-19.• Documented information from visits and lab tests and updated databases to improve analysis and ensure timely, organized data collection.

• 

  Elevance Health

  Sept 2022 - Feb 2023

  Carelon Rx Clinical Quality Prior Authorization Pharmacy Intern

  • Processed prior authorization requests and ensured compliance with Medicare and Medicaid requirements.• Interpreted appropriateness of prescriptions, troubleshot adjudication issues, and informed relevant parties of all prior authorization determinations.

• 

  Gilead Sciences

  Apr 2023 - May 2024

  • Developed a section of a slide deck focusing on post conference updates disseminated to Global Medical Affairs HIV teams.• Restructured a phase 4 HIV pre-exposure prophylaxis (PrEP) dashboard that presents ongoing collaborative research to senior leadership and streamlined a format to be more digestible, sortable, and easier to update with future studies.• Presented a journal club to medical affairs colleagues outlining a PrEP modality preference manuscript and integrated Gilead’s medical narrative to facilitate strategic discussions for lenacapavir’s investigational use as a long-acting injectable PrEP.• Updated a slide deck on TelePrEP implementation to inform medical affairs teams of the impact of concurrent HIV/AIDS and COVID-19 pandemics.• Contributed to a meta-analysis project with the liver diseases team collaborating with the Hepatitis B Foundation to develop over ten modules for provider education and certification.• Crafted a medical letter on Biktarvy and its off-label use as post-exposure prophylaxis (PEP), utilized to respond to more than 30 questions quarterly.• Developed insights to inform the global medical strategy team on frequently requested topics with regards to the investigational use of lenacapavir for HIV prevention, and strategically reviewed high-volume inquiries for lenacapavir for HIV treatment to plan for similar questions following lenacapavir’s approval for HIV PrEP.• Summarized medical information engagements and insights in a slide deck used to directly engage internal and external stakeholders on the latest data pertaining to lenacapavir’s investigational use for HIV PrEP. Show less

  • Clinical Development Extern

    May 2022 - May 2024

  • Global Medical Affairs and Medical Information Extern

    Apr 2023 - Jun 2023
• 

  Ultragenyx

  Sept 2023 - Nov 2023

  Global Medical Information and Communications Extern

  • Updated Standard Response Letter for DTX401 for the treatment and maintenance of Glycogen Storage Disease (GSD1a).• Restructured the Scientific Communications Platform for all Ultragenyx's rare disease indications to be easily editable in-house and updated with recent clinical trial data. Eliminated the need to source a vendor to maintain the platform, saving $20,000 per year.• Supported medical congress planning and booth deliverables.• Researched unsolicited medical information inquiries and prepared evidence-based responses in a timely manner.• Assisted with call center training.• Completed monthly quality assurance (QA) and metrics/insights reporting. Show less